<DOC>
	<DOCNO>NCT02443116</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , efficacy NGM282 patient nonalcoholic steatohepatitis .</brief_summary>
	<brief_title>Study NGM282 Patients With Nonalcoholic Steatohepatitis ( NASH )</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Males female , 18 75 year age , inclusive Histologically confirm NASH diagnosis Clinically significant acute chronic liver disease Prior liver transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>